Clinical trial
Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes…
NCT00455598 · Ionis Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00455598 |
|---|---|
| Title | Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea |
| Official title | A Phase 2, Multi Center, Randomized, Double Blind, Placebo Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, PK, & Activity of ISIS 113715 Administered Weekly in Subjects With Type 2 DM Treated w/ Sulfonylurea |
| Lead sponsor | Ionis Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | ISIS 113715 |
| Enrollment | 88 |
| Start date | Feb 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Apr 3, 2007 |
| Last update posted | Aug 28, 2009 |
| Countries | Poland, Romania, Russia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: